'FROM DISCOVERY TO RECOVERY'
Member of the Scientific Research Committee, Northern Ireland Chest Heart and Stroke Association, 2014-
Scientific advisor for the German Government. Appointed External Evaluator for the German Centre for Lung Research 2015
Work for the EU 2013-
Evaluator for IMI-JU-2012/2013 - IMI_ENSO_2 2013
Evaluator for COST applications 2015
Evaluator for Horizon 2020- topic "Understandiing disease: systems medicine"2014 (stage 1) and 2015 (stage 2)
I apologize for the varying font sizes but all text was the same font size when I pasted it into this box.
Other Committee Appointments
Research and Development Office, Northern Ireland
Member, Research and Development Office, Northern Ireland Health and Social Services, Central Services Agency Ad Hoc Group for the Award of Studentships (2009-2001)
EU Work (2009-20012)
Evaluator for Stage 1 of the Innovative Medicines Initiative Joint Undertaking (IMI JU) which is a public-private partnership between the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA). This involved evaluating the Expressions of Interest submitted by Applicant Consortia (i.e. consortia formed from academia, SMEs, patient organisations, non EFPIA industry, etc). The aim was to select the best Expression of Interest in order to join a pre-established Consortium of member companies of EFPIA (industry).
Selected evaluator for Stage 2 of the Innovative Medicines Initiative Joint Undertaking, which involved evaluating the Full Project Proposals from the successful Applicant Consortium and the pre-established Consortium of member companies of EFPIA (industry).
Rapporteur for the Interim Review of U-BIOPRED Project: “Unbiased Biomarkers for the Prediction of Respiratory Disease Outcome”. The role of the Rapporteur was to consolidate the consensus Review Report with the input from the other Reviewers, after a hearing meeting in Brussels. I was selected from the original panel of evaluators (from Stage 2). The other members of the review group were from the Scientific Committee of the IMI Joint Undertaking (IMI JU). I was the only person selected from the original evaluators to review the progress of the project.
Evaluator for Stage 1 of the FP7-HEALTH-2012-Innovation 1 applications in Systems Medicine. In this first stage, short proposals (5 pages) were submitted and evaluators selected the best ones. Selected proposals were then invited to submit a full proposal.
Evaluator for Stage 2 of the FP7-HEALTH-2012-Innovation 1 applications in Systems Medicine for the topic 2.1-2-2 "Systems medicine: Applying systems biology approaches for understanding multifactorial human diseases and their co-morbidities."
Scientific Expert for German Government (2010-2011)
In a unique effort to establish six National Centres for Research in the fields of the most common diseases a National Centre for Lung Research was planned. The German Federal Ministry of Education and Research (BMBF) spending on this centre is of the order of more than 100 million Euro over the first 5 years. The aim of the BMBF was to develop a centrally coordinated research hub for this important research area in Germany. I was selected as one of the review panel of internationally renowned experts in the field. This work entailed: firstly evaluating all the proposals from potential centre partners and the pre-selection of 12 partners to submit to the second stage; secondly evaluating the second stage applications which included also hearing them present their proposals which resulted in the selection of the partners for the centre and thirdly reviewing the joint proposal developed by the partners specifically for its scientific and structural integrity, the long-term strategy and sustainability as well as and most importantly, the added value for the area of lung research in Germany. This work entailed reviewing at home as well as 3 trips to Germany for the meetings.
Review of manuscripts for journals
I serve as a referee for the following journals: Allergy, American Journal of Respiratory and Critical Care Medicine, Biochemical Pharmacology, British Journal of Pharmacology, Clinical and Experimental Allergy, European Journal of Pharmacology, European Respiratory Journal, Immunopharmacology, Inflammation Research, Journal of Leukocyte Biology, Journal of Pharmacy and Pharmacology, Life Sciences, Pediatric Allergy and Immunology, Pediatric Pulmonology, Pulmonary Pharmacology & Therapeutics, Thorax.
Membership of Professional Bodies
(i) British Pharmacological Society
(ii) British Society for Immunology
(iii) British Society for Allergy and Clinical Immunology
(iv) British Thoracic Society (Member of Council and the Research and Scientific Committee 2010 onwards)
(v) European Academy of Allergy and Clinical Immunology
(vi) European Cystic Fibrosis Society
(vii) European Histamine Research Society (Past President of Society)
(viii) European Respiratory Society
(ix) Irish Thoracic Society
(x) Ulster Immunology Group
I have been an active member of the organising committees of the annual European Histamine Research Society meetings since 1998.
In 2012, the meeting was held for the first time in the island of Ireland and I am responsible for organisation. See my conference website (www.qub.ac.uk/EHRS2012). Although nominally European,the delegates were from 29 countries including USA, Japan, Argentina and Mexico as well as European Countries.
In my role as member of the Science and Research Committee of the British Thoracic Society, I was responsible for helping to organise the Annual Winter Meeting. In 2011, I was responsible for 1 symposium and for 2012 I organised 3 symposia.
I organised and chaired a workshop entitled “Therapeutic potential of histamine H4 receptor compounds” which was held during the European Academy of Allergy and Clinical Immunology (EAACI) 2010 Meeting.
Honorary member of the Polish Histamine Research Society – elected and awarded November 2002
Honorary member of the European Histamine Research Society – elected May 2008 awarded May 2009